InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by RAPPAPORT ANDREW. Director active across 1 company, notably Olema Pharmaceuticals, Inc.. Aggregated, 1 disclosures have been logged. Activity tracked since 5 March 2024. The latest transaction was disclosed on 5 March 2024 (J). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration